Theravance Biopharma, Inc. Income Statement

Income Statement Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 130.15M0.23M11.69M15.00M15.00M15.39M60.37M73.41M71.86M55.31M51.35M57.42M64.38M
Cost of Revenue 4.06M4.66M2.89M6.03M
Gross Profit 130.15M0.23M7.63M10.34M12.11M9.36M60.37M73.41M71.86M55.31M51.35M57.42M64.38M
Operating items
Research & Development 114.00M120.58M168.52M129.16M141.71M173.89M201.35M219.25M260.95M193.66M63.39M40.62M37.64M
Selling, General & Administrative 25.73M35.93M71.65M90.20M84.51M95.59M97.06M106.08M108.53M99.30M67.07M70.09M69.17M
Restructuring Costs 20.14M12.84M2.74M
Other Operating Expenses 4.06M4.66M2.89M6.03M0.71M4.51M
Operating Expenses 139.72M156.51M244.23M224.03M229.12M275.51M299.12M325.33M369.48M313.10M143.30M113.46M111.33M
Operating Income -9.57M-156.28M-232.54M-181.90M-180.47M-260.12M-238.75M-251.91M-297.63M-257.78M-91.96M-56.03M-46.95M
EBIT -9.57M-156.28M-232.54M-181.90M-180.47M-260.12M-238.75M-251.91M-297.63M-257.78M-91.96M-56.03M-46.95M
Non-operating items
Other Non Operating Income 1.86M0.63M1.31M4.79M11.97M8.39M2.83M1.11M8.54M9.12M4.88M
Non Operating Income 1.86M0.63M1.31M4.79M11.97M8.39M2.83M1.11M8.54M9.12M4.88M
Net income details
EBT -9.57M-156.28M-230.67M-181.27M-180.56M-271.71M-226.09M-241.68M-303.34M-265.22M-92.81M-49.27M-44.61M
Tax Provisions 6.36M0.95M10.11M13.70M-10.60M-5.22M-8.52M-0.20M-0.01M5.92M19.38M
Profit After Tax -9.57M-156.28M-237.04M-182.22M-190.67M-285.40M-215.52M-236.46M-294.82M-265.07M872.13M-55.19M-56.42M
Equity Income 0.17M11.18M33.70M68.44M103.99M
Income from Continuing Operations -9.57M-156.28M-237.04M-182.22M-190.67M-285.41M-215.49M-236.46M-294.82M-265.02M-92.81M-55.19M-63.99M
Consolidated Net Income -9.57M-156.28M-237.04M-182.22M-190.67M-285.41M-215.49M-236.46M16.81M65.64M1143.93M-55.19M-63.99M
Income towards Parent Company -9.57M-156.28M-237.04M-182.22M-190.67M-285.41M-215.49M-236.46M16.81M65.64M1143.93M-55.19M-63.99M
Net Income towards Common Stockholders -9.57M-156.28M-237.04M-182.22M-190.67M-285.41M-215.49M-236.46M16.81M65.64M1143.93M-55.19M-63.99M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 32.26M32.23M37.84M51.94M54.10M55.41M62.52M63.98M73.70M62.86M48.16M49.17M
Shares Outstanding (Diluted Average) 55.61M62.34M69.46M73.59M55.30M48.85M
EBITDA -9.57M-156.28M-232.54M-181.90M-180.47M-260.12M-238.75M-251.91M-297.63M-257.78M-91.96M-56.03M-46.95M
Tax Rate 4.69%2.16%2.81%0.08%0.01%